Description:

RTOG-0617 F1: Radiation Therapy Oncology Group Phase III Lung Pre-Op Chemotherapy vs. Pre-Op Concurrent Chemoradiation for NSCLC Follow-up Form High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=24F6F134-391D-15F5-E044-0003BA3F9857

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=24F6F134-391D-15F5-E044-0003BA3F9857

Keywords:
Versions (5) ▾
  1. 9/19/12
  2. 1/9/15
  3. 1/9/15
  4. 2/5/19
  5. 2/5/19
Copyright Holder:
NCI
Uploaded on:

February 5, 2019

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Lung Cancer NCT00533949 Follow-Up - RTOG-0617 F1: Radiation Therapy Oncology Group Phase III Lung Pre-Op Chemotherapy vs. Pre-Op Concurrent Chemoradiation for NSCLC Follow-up Form - 2556229v1.0

INSTRUCTIONS: Submit this form at the appropriate followup interval and whenever there is a change in the patient's status. Dates are mm-dd-yyyy unless otherwise specified.

  1. StudyEvent: RTOG-0617 F1: Radiation Therapy Oncology Group Phase III Lung Pre-Op Chemotherapy vs. Pre-Op Concurrent Chemoradiation for NSCLC Follow-up Form
    1. INSTRUCTIONS: Submit this form at the appropriate followup interval and whenever there is a change in the patient's status. Dates are mm-dd-yyyy unless otherwise specified.
Module 1
Module 2
Has Patient Been Diagnosed With A New Progression?
Report All Continuing Or New Adverse Events